BONA
Bona® , a global, sustainably-driven company that supplies products for installing, renovating, maintaining, and restoring premium floors, and Scania, one of the world's leading providers of transport solutions, hosted an event yesterday to welcome Bona’s first electric truck to its facility in Limburg, Germany. The Scania innovated truck is from the Scania P series and will offer an emission-free transport system for Bona’s operations in Limburg and the surrounding area. It is the first of its kind to be operated in Germany.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211130005952/en/
"Bona is committed to incorporating and pursuing sustainable products, systems, and practices throughout the company and the new Scania electric truck is an important milestone in our journey to a greener future,” said Dr. Thomas Brokamp, Managing Director, Bona Germany. “Scania advised us well on the choice of our electric vehicle and gave us a good introduction to this new technology. The Scania electric truck is perfectly tailored to our needs and areas of operation.” The battery-electric truck will act as a city shuttle, making multiple trips a day to transport finished products from the production plant in the south of the city to the distribution center in the north, just under six kilometers away. Approximately 21 euro pallets can be accommodated in the loading area on each tour.
A POWERFUL DRIVE SYSTEM AND COMFORTABLE RIDE
The new model in the Scania P series, called the Scania 25 P, was specially designed for inner-city use and is characterized by comfortable access to the cab and excellent traffic visibility. The number in the model designation indicates the power that the truck travels, up to 230 kW (312 hp) rated engine power, which is enough power to move the three-axle truck's permissible weight of 26 tons with ease.
"The electric powertrain shines, especially at low engine speeds and in starting situations, with significantly better acceleration and more tractive power compared to a diesel truck," said Christian Hottgenroth, Director of Truck Sales, Scania Germany Austria. “In practice, drivers can therefore look forward to rapid acceleration and short response times from the drive.”
The Scania 25 P stores the energy for propulsion in five lithium-ion batteries, each with a capacity of 33 kW/h. "The electric range depends primarily on the factors of driving style, load, as well as topography," Hottgenroth explained further. Under optimal conditions, the drive batteries with the total capacity of 165 kW/h are designed for a range of up to 110 kilometers, while 70 to 90 kilometers can be expected in real driving conditions. For Bona’s use in the city of Limburg, which will average approximately 50 kilometers per day, the power is completely sufficient for the planned operating profile.
POWERED WITH SUSTAINABLE ENERGY
Because Bona’s Limburg facility is equipped with solar panels, the new Scania truck will be fueled by green electricity generated by a powerful photovoltaic system on the roof of the large hall. The fully electric truck is charged with direct current and is equipped with a charging capacity of 130 kW, which allows the batteries to be fully charged in about an hour at 20 percent capacity. If more range is required, a stop of half an hour at the charging station is enough to charge energy for another 50 or 60 kilometers.
“Moving to an emission-free vehicle is an important part of our broader sustainability journey and part of our commitment to be a good citizen. Due to high traffic the city of Limburg has a problem with excessively high nitrogen dioxide levels. The main source are diesel vehicles, and it is now extremely likely a ban for these vehicles is coming 1st of April 2022 for Limburg. With our emission-free truck we can make a valuable contribution in Limburg to lower nitrogen dioxide levels and to global decarbonization," said Dr. Brokamp. The fact that the electric truck from Scania also runs locally with zero emissions and is virtually noise-free due to its low-noise drive are also benefits of the all-electric truck.
Bona is in the process of finalizing the electric charging station, which is slated for completion by early 2022.
ABOUT BONA
Bona is a family-owned, sustainably-driven company that supplies products for installing, renovating, maintaining, and restoring premium floors. Founded in 1919, Bona was the first in the industry to offer a full system of waterborne hardwood floor finishing and floor care products. Today, Bona offers products for most premium floor surfaces including wood, tile, vinyl, resilient, rubber, and laminate. Bona’s turnover is 3.1bn SEK (EUR 307 million) 2020. The head office is in Malmö, Sweden, and the company is represented globally by its 17 subsidiaries, 70 distributors, 600 employees, and 5 factories. For more, visit www.bona.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211130005952/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom